BioLegend Revenue and Competitors
Estimated Revenue & Valuation
- BioLegend's estimated annual revenue is currently $128M per year.
- BioLegend's estimated revenue per employee is $155,000
Employee Data
- BioLegend has 826 Employees.
- BioLegend grew their employee count by 6% last year.
BioLegend's People
Name | Title | Email/Phone |
---|---|---|
1 | General Counsel and VP, Administration | Reveal Email/Phone |
2 | Sr. VP, Quality, Regulatory Affairs, & Compliance | Reveal Email/Phone |
3 | VP Finance | Reveal Email/Phone |
4 | VP, Operations | Reveal Email/Phone |
5 | SVP Business Operations | Reveal Email/Phone |
6 | Head Research And Development Adm. Cell Analysis | Reveal Email/Phone |
7 | VP Marketing & Scientific Applications | Reveal Email/Phone |
8 | Head, Custom Solutions Team | Reveal Email/Phone |
9 | VP Human Resources | Reveal Email/Phone |
10 | VP Research And Development | Reveal Email/Phone |
BioLegend Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is BioLegend?
BioLegend develops world-class, cutting-edge antibodies, recombinant proteins, bioassays, and other reagents for biomedical research, manufactured in our state-of-the-art facility in San Diego, California. Our mission is to accelerate research and discovery by providing the highest quality products at an outstanding value, along with superior customer service and technical support. BioLegend was incorporated in June, 2002. The founder and CEO of BioLegend, Gene Lay, D.V.M., who was also the co-founder of PharMingen.
keywords:Biotechnology,Healthcare,PharmaceuticalsN/A
Total Funding
826
Number of Employees
$128M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
BioLegend News
2 (Biolegend, clone 104)]. Detection of Apoptosis. Annexin V labeling and detection were performed with the fluorescein isothiocyanateannexin V...
AmideBio, Cambridge Research Biochemicals, BioLegend, AnaSpec, rPeptide, Genscript, Bio-Synthesis, NovoPro Inc., Bachem.
The affirmation following PKI's eight acquisitions in 2021, notably BioLegend which incurred $2.9 billion in additional debt,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $209.2M | 830 | 17% | N/A |
#2 | $241.4M | 841 | 6% | N/A |
#3 | $188.8M | 843 | 51% | N/A |
#4 | $243.1M | 847 | 5% | N/A |
#5 | $170M | 849 | 31% | $218M |